E-LIB Suche - Ergebnisse für: Schlegel, J. U.

1

P11.20.B ASSOCIATION OF HAND-FOOT SKIN REACTIONS WITH SURVI..:

Werner, J ; Hau, P ; Kowalski, T...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii76-ii77 , 2023

Link: https://doi.org/10.1093/..

2

P11.16.A Questioning convention - is intrathecal chemothera..:

Tuohy, K ; Aregawi, D ; Seidel, S...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii59-ii59 , 2022

Link: https://doi.org/10.1093/..

3

Improvement of functional outcome for patients with newly d..:

Wick, A. ; Sander, A. ; Koch, M....
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

4

66/m mit subakutem organischen Psychosyndrom: Vorbereitung ..:

Seidel, S. ; Schlegel, U.
DGNeurologie. 4 (2020) S1 - p. 8-10 , 2020

Link: https://doi.org/10.1007/..

5

P14.108 Bevacizumab versus alkylating chemotherapy in recur..:

Seystahl, K ; Hentschel, B ; Loew, S...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii93-iii94 , 2019

Link: https://doi.org/10.1093/..

6

PROSPECTIVE MULTICENTER REGISTRY FOR SECONDARY CNS INVOLVEM..:

Lammer, F. ; May, L. ; Martus, P....
Hematological Oncology. 37 (2019) S2 - p. 255-256 , 2019

Link: https://doi.org/10.1002/..

7

DNA methylation, transcriptome and genetic copy number sign..:

Binder, H. ; Willscher, E. ; Loeffler-Wirth, H....
Acta Neuropathologica Communications. 7 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

8

OS08.8 A head-to-head comparison of two different high dose..:

Rieger, L. ; Schlegel, U. ; Le Coutre, P....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii17-iii17 , 2017

Link: https://doi.org/10.1093/..

9

P14.10 Secondary CNS involvement in malignant lymphoma: Dat..:

Korfel, A. ; Schroers, R. ; Schlegel, U....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii104-iii104 , 2017

Link: https://doi.org/10.1093/..

10

Episodische zentrale Hypopnoe und Hypotonie: Folge einer Ei..:

Ismail, F. S. ; Schlegel, U. ; Kowoll, A..
Der Nervenarzt. 89 (2017) 6 - p. 699-700 , 2017

Link: https://doi.org/10.1007/..

11

CURRENT THERAPY OF SECONDARY CNS INVOLVEMENT IN MALIGNANT L..:

Korfel, A. ; Schroers, R. ; Schlegel, U....
Hematological Oncology. 35 (2017) S2 - p. 196-197 , 2017

Link: https://doi.org/10.1002/..

12

OS3.4 Effect of bevacizumab on the morphology and function ..:

Latzer, P. ; Theiss, C. ; Schlegel, U.
Neuro-Oncology. 18 (2016) suppl_4 - p. iv7-iv7 , 2016

Link: https://doi.org/10.1093/..

13

Primäre ZNS-Lymphome: Fortschritte in der Diagnostik und Th..:

Korfel, A. ; Schlegel, U.
Der Nervenarzt. 86 (2015) 6 - p. 710-715 , 2015

Link: https://doi.org/10.1007/..

14

Intravenous levetiracetam in clinical practice – Results fr..:

Lang, N. ; Esser, W. ; Evers, S....
Seizure. 29 (2015) - p. 109-113 , 2015

Link: https://doi.org/10.1016/..

15

Hämatologische Spezialdiagnostik und Therapieoptionen bei o..:

Korfel, A. ; Schlegel, U. ; Schroers, R.
Der Ophthalmologe. 112 (2015) 3 - p. 231-236 , 2015

Link: https://doi.org/10.1007/..